Protagonist Therapeutics Inc (NASDAQ:PTGX)

13.14
Delayed Data
As of Jul 19
 -0.15 / -1.13%
Today’s Change
5.49
Today|||52-Week Range
14.36
+95.25%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Protagonist Therapeutics Inc have a median target of 17.50, with a high estimate of 29.00 and a low estimate of 17.00. The median estimate represents a +33.18% increase from the last price of 13.14.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Protagonist Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$11.2M
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 51.72%
 
 
 
 
 
 
Growthannually -18.87%
 
 
 
 
 

Sales

Growthquarterly 617.95%
 
 
 
 
 
 
Growthannually -41.45%
 
 
 
 
 
Key to the earnings and sales forecast charts.